Key points are not available for this paper at this time.
A better understanding of the immunomodulatory effects of each ITP therapy is needed to best manage the disease.
Perera et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: